Technical Analysis for SRRA - Sierra Oncology, Inc.

Grade Last Price % Change Price Change
grade D 1.85 -0.54% -0.01
SRRA closed down 0.54 percent on Monday, March 18, 2019, on 1.22 times normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Flat
See historical SRRA trend table...

Date Alert Name Type % Chg
Mar 18 200 DMA Resistance Bearish 0.00%
Mar 18 Shooting Star Candlestick Bearish 0.00%
Mar 18 Doji - Bearish? Reversal 0.00%
Mar 14 180 Bullish Setup Bullish Swing Setup -2.63%
Mar 13 Narrow Range Bar Range Contraction 1.09%
Mar 13 NR7 Range Contraction 1.09%
Mar 13 Inside Day Range Contraction 1.09%
Mar 12 Wide Bands Range Expansion 0.54%
Mar 11 MACD Bearish Signal Line Cross Bearish 0.54%
Mar 11 Wide Bands Range Expansion 0.54%

Older signals for SRRA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Sierra Oncology, Inc. is a clinical-stage drug development company. It develops and markets drugs for the treatment of cancer. The product pipeline consists of SRA737 and SRA141. SRA737 is an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, a key cell cycle checkpoint and central regulator of the DNA Damage Response network. SRA141 is an orally available small molecule inhibitor of cell division cycle 7kinase. Sierra Oncology, Inc., formerly known as ProNAi Therapeutics, Inc., is headquatered in Vancouver, Canada.
Medicine Cancer Chemical Compounds Treatment Of Cancer Drug Discovery Drug Development Tyrosine Kinase Inhibitors Protein Kinase Inhibitors Small Molecule
Is SRRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.7
52 Week Low 1.05
Average Volume 216,034
200-Day Moving Average 1.9753
50-Day Moving Average 1.5756
20-Day Moving Average 1.819
10-Day Moving Average 1.859
Average True Range 0.1026
ADX 40.36
+DI 28.8573
-DI 10.9879
Chandelier Exit (Long, 3 ATRs ) 1.7022
Chandelier Exit (Short, 3 ATRs ) 1.8278
Upper Bollinger Band 2.0048
Lower Bollinger Band 1.6332
Percent B (%b) 0.58
BandWidth 20.428807
MACD Line 0.0848
MACD Signal Line 0.0984
MACD Histogram -0.0136
Fundamentals Value
Market Cap 96.7 Million
Num Shares 52.3 Million
EPS -1.18
Price-to-Earnings (P/E) Ratio -1.57
Price-to-Sales 0.00
Price-to-Book 0.98
PEG Ratio -0.04
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.08
Resistance 3 (R3) 2.10 2.04 2.04
Resistance 2 (R2) 2.04 1.99 2.03 2.02
Resistance 1 (R1) 1.95 1.95 1.92 1.93 2.01
Pivot Point 1.89 1.89 1.88 1.88 1.89
Support 1 (S1) 1.80 1.84 1.77 1.78 1.69
Support 2 (S2) 1.74 1.80 1.73 1.68
Support 3 (S3) 1.65 1.74 1.66
Support 4 (S4) 1.63